Alison Palmer Selected Research

Alison Palmer Research Topics

5	Myocardial Infarction 09/2009 - 02/2003
3	Coronary Disease (Coronary Heart Disease) 08/2006 - 02/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2007 - 02/2003
1	Non-Muscle Invasive Bladder Neoplasms 01/2019
1	Transitional Cell Carcinoma 01/2019
1	Vascular Diseases (Vascular Disease) 09/2009
1	Obesity 09/2009
1	Inflammation (Inflammations) 04/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2007
1	Cardiotoxicity 02/2003

3	ApolipoproteinsIBA 09/2009 - 02/2003
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2009 - 07/2007
2	HDL CholesterolIBA 09/2009 - 07/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2009 - 07/2007
2	LipidsIBA 07/2007 - 10/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	Celecoxib (Celebrex)FDA Link 01/2019
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019
1	Apolipoproteins AIBA 09/2009
1	Apolipoproteins B (ApoB)IBA 09/2009
1	oxidized low density lipoproteinIBA 09/2009
1	LDL CholesterolIBA 09/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2008
1	lipoprotein cholesterolIBA 07/2007
1	CholesterolIBA 07/2007
1	Fibrinogen (Factor I)FDA Link 08/2006
1	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2006
1	Apolipoproteins E (ApoE)IBA 02/2003
1	Apolipoprotein E2IBA 02/2003

2	Therapeutics 01/2019 - 07/2007